Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma.

D. Elsasser; H. Stadick; S. Stark; J.G.J. van de Winkel; M. Gramatzki; K.M. Schrott; T. Valerius; W. Schafhauser

Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma.

Translated title of the contribution: Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma.

D. Elsasser, H. Stadick, S. Stark, J.G.J. van de Winkel, M. Gramatzki, K.M. Schrott, T. Valerius, W. Schafhauser

Center for Translational Immunology (CTI)

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma.
Original language	Undefined/Unknown
Pages (from-to)	1525-1528
Number of pages	4
Journal	Anticancer Research
Volume	19
Issue number	2C
Publication status	Published - 1999

Cite this

@article{aab2252eba1348c7a667d914a1010eee,

title = "Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma.",

author = "D. Elsasser and H. Stadick and S. Stark and \{van de Winkel\}, J.G.J. and M. Gramatzki and K.M. Schrott and T. Valerius and W. Schafhauser",

year = "1999",

language = "Undefined/Unknown",

volume = "19",

pages = "1525--1528",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "2C",

}

TY - JOUR

T1 - Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma.

AU - Elsasser, D.

AU - Stadick, H.

AU - Stark, S.

AU - van de Winkel, J.G.J.

AU - Gramatzki, M.

AU - Schrott, K.M.

AU - Valerius, T.

AU - Schafhauser, W.

PY - 1999

Y1 - 1999

M3 - Article

SN - 0250-7005

VL - 19

SP - 1525

EP - 1528

JO - Anticancer Research

JF - Anticancer Research

IS - 2C

ER -